Review: could Remicade cause Chest injury?
Summary: Chest injury could be caused by Remicade, especially for people who are male, 30-39 old, have been taking the drug for 1 - 2 years, also take Novolog, and have Diabetes mellitus.
We study 85,034 people who have side effects while taking Remicade from FDA and social media. Among them, 2 have Chest injury. Find out below who they are, when they have Chest injury and more.
How are my drugs for patients like me? On eHealthMe, you can research 300 million drug outcomes from FDA and social media. All studies are personalized to gender and age. Start now, it's anonymous, simple & free >>>
Remicade (latest outcomes from 85,433 users) has active ingredients of infliximab. It is often used in crohn's disease.
Chest injury (latest reports from 1,955 patients) has been reported by people with osteoporosis, depression, pain, high blood pressure, high blood cholesterol.
On Apr, 18, 2014: 85,034 people reported to have side effects when taking Remicade. Among them, 2 people (0.00%) have Chest Injury. They amount to 0.10% of all the 1,953 people who have Chest Injury on eHealthMe.
Time on Remicade when people have Chest injury * :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years |
|Chest injury||0.00%||0.00%||0.00%||66.67%||33.33%||0.00%||0.00% |
Gender of people who have Chest injury when taking Remicade * :
|Chest injury||0.00%||100.00% |
Age of people who have Chest injury when taking Remicade * :
|Chest injury||0.00%||0.00%||0.00%||0.00%||85.71%||0.00%||0.00%||14.29% |
Severity of Chest injury when taking Remicade ** :
How people recovered from Chest injury ** :
Top conditions involved for these people * :
- Diabetes mellitus (2 people, 100.00%)
- Psoriatic arthropathy (2 people, 100.00%)
- Psoriasis (2 people, 100.00%)
- Ankylosing spondylitis (1 people, 50.00%)
Top co-used drugs for these people * :
- Novolog (2 people, 100.00%)
- Lantus (2 people, 100.00%)
- Methotrexate (2 people, 100.00%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Related topic: Remicade, Chest injury
You can also:
On eHealthMe, Remicade (infliximab) is often used for crohn's disease. Find out below the conditions Remicade is used for, how effective it is, and any alternative drugs that you can use to treat those same conditions.
What is Remicade used for and how effective is it:
Other drugs that are used to treat the same conditions:
Could it be a symptom from a condition:
Drugs in real world that are associated with:
Could your condition cause it?
Comments from related studies:
From this study (1 month ago):
Sporadic hot irritating flushing at random times. Sometimes painfull
Post a new comment OR Read more comments
Can you answer these questions (what is this?):
More questions for: Remicade, Chest injury
More reviews for: Remicade, Chest injury
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.